2nd Quarter - Amendment

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Period 2nd Quarter 2013 Filed Feb 20, 2014 Signed by Francesca Fierro O'Reilly, Vice President, Government Relations

Official filing
Firm
AMERICAN CLINICAL LABORATORY ASSN
Client
AMERICAN CLINICAL LABORATORY ASSN
Income
—
Expenses
$206,134
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 19, 2013 $206,134 Replaced
2nd Quarter - Amendment (this page) Feb 20, 2014 $206,134 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicare Clinical Laboratory Fee Schedule and Physician Fee Schedule reimbursement and coverage issues, including gapfill pricing for molecular diagnostic tests and proposed regulatory and legislative cuts. Proposed FDA regulation of laboratory-developed tests. Closing the in-office ancillary services exception to the Stark self-referral law.

LobbyistCovered position, as disclosed
JO ANNE GLISSON —
SCOTT VAN BUREN MCGOOHAN —
ALAN MERTZ —
FRANCESCA FIERRO O'REILLY —
THOMAS B SPARKMAN —

Contacted: Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Office of Management & Budget (OMB); President of the U.S.; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare Clinical Laboratory Fee Schedule and Physician Fee Schedule reimbursement and coverage issues, including gapfill pricing for molecular diagnostic tests and proposed regulatory and legislative cuts. Proposed FDA regulation of laboratory-developed tests. Closing the in-office ancillary services exception to the Stark self-referral law.

LobbyistCovered position, as disclosed
JO ANNE GLISSON —
SCOTT VAN BUREN MCGOOHAN —
ALAN MERTZ —
FRANCESCA FIERRO O'REILLY —
THOMAS B SPARKMAN —

Contacted: Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); President of the U.S.; Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Government Accountability Office (GAO); SENATE; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Medicare Clinical Laboratory Fee Schedule and Physician Fee Schedule reimbursement and coverage issues, including gapfill pricing for molecular diagnostic tests and proposed regulatory and legislative cuts. Proposed FDA regulation of laboratory-developed tests. Closing the in-office ancillary services exception to the Stark self-referral law.

LobbyistCovered position, as disclosed
JO ANNE GLISSON —
SCOTT VAN BUREN MCGOOHAN —
ALAN MERTZ —
FRANCESCA FIERRO O'REILLY —
THOMAS B SPARKMAN —

Contacted: Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); President of the U.S.; Congressional Budget Office (CBO); SENATE

Medical/Disease Research/Clinical Labs MED

Medicare Clinical Laboratory Fee Schedule and Physician Fee Schedule reimbursement and coverage issues, including gapfill pricing for molecular diagnostic tests and proposed regulatory and legislative cuts. Proposed FDA regulation of laboratory-developed tests. Closing the in-office ancillary services exception to the Stark self-referral law.

LobbyistCovered position, as disclosed
JO ANNE GLISSON —
SCOTT VAN BUREN MCGOOHAN —
ALAN MERTZ —
FRANCESCA FIERRO O'REILLY —
THOMAS B SPARKMAN —

Contacted: Health & Human Services, Dept of (HHS); President of the U.S.; Food & Drug Administration (FDA); Government Accountability Office (GAO); Congressional Budget Office (CBO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.